Publications

Found 7 results
Filters: Author is J. Yan  [Clear All Filters]
2013
H. L. Yang, Yan, J., Feng, M., Tan, X., Yan, G. Y., Gan, L., and Sun, C., Construction of suppressor of cytokine signaling 2 (SOCS2) adenoviral overexpression vector and its impact on growth-hormone-induced lipolysis in swine primary adipocytes, vol. 12, pp. 1283-1293, 2013.
Berryman DE, List EO, Coschigano KT, Behar K, et al. (2004). Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14: 309-318. http://dx.doi.org/10.1016/j.ghir.2004.02.005 PMid:15231300   Flores-Morales A, Fernandez L, Rico-Bautista E, Umana A, et al. (2001). Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway. Mol. Endocrinol. 15: 1471-1483. http://dx.doi.org/10.1210/me.15.9.1471 PMid:11518796   Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, et al. (2002). Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277: 40181-40184. http://dx.doi.org/10.1074/jbc.C200450200 PMid:12208853   Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, et al. (2005). SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115: 397-406. PMid:15690087 PMCid:546423   Johansen T, Richelsen B, Hansen HS, Din N, et al. (2003). Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm. Metab. Res. 35: 243-250. http://dx.doi.org/10.1055/s-2003-39481 PMid:12778368   Kawai M, Namba N, Mushiake S, Etani Y, et al. (2007). Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 38: 19-34. http://dx.doi.org/10.1677/jme.1.02154 PMid:17242167   Leung KC, Doyle N, Ballesteros M, Sjogren K, et al. (2003). Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. U. S. A. 100: 1016-1021. http://dx.doi.org/10.1073/pnas.0337600100 PMid:12552091 PMCid:298718   Louveau I and Gondret F (2004). Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system. Domest. Anim. Endocrinol. 27: 241-255. http://dx.doi.org/10.1016/j.domaniend.2004.06.004 PMid:15451072   Metcalf D, Greenhalgh CJ, Viney E, Willson TA, et al. (2000). Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405: 1069-1073. http://dx.doi.org/10.1038/35016611 PMid:10890450   Miller ME, Michaylira CZ, Simmons JG, Ney DM, et al. (2004). Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127: 570-581. http://dx.doi.org/10.1053/j.gastro.2004.05.016 PMid:15300589   Ng FM, Jiang WJ, Gianello R, Pitt S, et al. (2000). Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats. J. Mol. Endocrinol. 25: 287-298. http://dx.doi.org/10.1677/jme.0.0250287 PMid:11116208   Ouyang X, Fujimoto M, Nakagawa R, Serada S, et al. (2006). SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J. Cell Physiol. 207: 428-436. http://dx.doi.org/10.1002/jcp.20579 PMid:16419040   Pasarica M, Zachwieja JJ, Dejonge L, Redman S, et al. (2007). Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 92: 4265-4270. http://dx.doi.org/10.1210/jc.2007-0786 PMid:17785361   Paul C, Seiliez I, Thissen JP and Le CA (2000). Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur. J. Biochem. 267: 5849-5857. http://dx.doi.org/10.1046/j.1432-1327.2000.01395.x PMid:10998044   Plockinger U and Reuter T (2008). Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. Eur. J. Endocrinol. 158: 467-471. http://dx.doi.org/10.1530/EJE-07-0637 PMid:18362292   Rico-Bautista E, Negrin-Martinez C, Novoa-Mogollon J, Fernandez-Perez L, et al. (2004). Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Exp. Cell Res. 294: 269-280. http://dx.doi.org/10.1016/j.yexcr.2003.11.017 PMid:14980520   Stewart WC, Baugh JE Jr, Floyd ZE and Stephens JM (2004). STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 324: 355-359. http://dx.doi.org/10.1016/j.bbrc.2004.09.053 PMid:15465026   Sun C, Wang L, Yan J and Liu S (2012a). Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol. Biol. Rep. 39: 1755-1763. http://dx.doi.org/10.1007/s11033-011-0916-x PMid:21633889   Sun C, Qi R, Wang L, Yan J, et al. (2012b). p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice. Mol. Biol. Rep. 39: 3179-3184. http://dx.doi.org/10.1007/s11033-011-1084-8 PMid:21701827   Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Sahlin L, et al. (1999). Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140: 3693-3704. http://dx.doi.org/10.1210/en.140.8.3693 PMid:10433229   Turnley AM (2005). Role of SOCS2 in growth hormone actions. Trends Endocrinol. Metab. 16: 53-58. http://dx.doi.org/10.1016/j.tem.2005.01.006 PMid:15734145   Zhang Y, Zhao J, Zhang H, Gai Y, et al. (2010). The involvement of suppressors of cytokine signaling 2 (SOCS2) in immune defense responses of Chinese mitten crab Eriocheir sinensis. Dev. Comp. Immunol. 34: 42-48. http://dx.doi.org/10.1016/j.dci.2009.08.001 PMid:19686773